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Editorial Comment 
Surgical Therapy for Atrial 
Fibrillation: A First Step on What 
May Be a Long Road* 
JOHN P. DtMAKCO, MD, PHD 
Clrurlorrurl4lr. “ircbirr 
Atria! fibrillation. although not usually considered B Me- 
threatening arrhythmia. remains a major clinical problem 
because of its prevalence, its production of sympmms that 
may range from minm to disabling. its awxiation with 
embolic events and its poor response to pharmacologic 
therapy. In this issue of the Journal. Leitch and his cowork- 
ers II) describe the effects of a new surgical procedure. the 
“corridor operation.” in patients with refractory. sympto- 
matic atrial fibrillation. Although the results reported show 
only little or no benefit over that possible with esrablished 
allemative approaches. the work represents an innovative 
first step toward new thinking about approaches to this old 
arrhythmia. 
At&d fibrillation: the elinieal pro&m. Atrial fibrillation 
is probably the most common swained arrhythmia. occur- 
ring in up to 0.4% of B general adult population 12.3). It is 
associated with virtually all forms of structural cardiac 
disease but may also occw in other settings such as 
thyrotoxicosis. conduction system disorders. alcohol or 
other substance ingestion. as well as in patients without 
identifiable predisposing factors. The hemcdynamic conse- 
quences of mrial fibrillation may include abnormal ventric- 
ular rales at rest or in response to normal stimuli. or both. 
and loss of the alrial contribution to cardiac output. a 
problem panicularly affecting patients with noncompliant 
ventricles or with depressed ventricular function. Thrombo- 
embolic events are the most dreaded complicalions oiatrial 
fibri!lation and the risk for such events increase with increas- 
ing severily of associated cardiovascular disease (4-Q. The 
princ;ples guiding the management of patients with atrial 
fibrillation have traditionsty included initial trials of phar- 
macologic therapy to maintain sinus rhythm. control of 
ventricular r&e if sinus rhythm cannm be maintained. and 
atticoagtdant therapy with either warfarin or aspirin to 
prevent embolic eventr. None of these approaches is uni- 
formly successiul and the use of the most commonly admin. 
irtered antiarrhythmic drug. qtdnidine. to maintain sinus 
rhythm war recently called into question by a mcta-analysis 
17) suggesting a higher mortality rate arsociilted with such 
administration. 
The present study: “cwridsr oantlmtn.” Surgical ther- 
apy for cardiac arrhythmias has b&n most succ&sful when 
B specific region of the heart is identified as the source ofthe 
arrhythmia and is excised or ablated. Because it involves the 
entire atrium. atrial fibrillation has previously nal been 
thwghl lo be suwptible to this type of approach. Leitch et 
al. 1 I I have devised an operation that isolates the majority of 
the atria imm the sinus node and a strip of atrial tissue 
connecting it to the AV node and His bundle, thus leaving 
intact the chronotropic function of the sinus node. Seven of 
their nine patients no longer had atrial fibrillation controlling 
their heart rate after operation but four patients required 
pacemaker inwtion because of postoperative sinus node 
dysfunction. 
In terms of the accepted goals of therapy in patients with 
atrial fibrillation. the “corridor” operation offers prospects 
of only limited EUCCCSE. The hemodynamic functions of 
the atria are nm restored and there is little reason to suspect 
that tbe risk for cl01 formation in the atria will be reduced. 
Although the n~rntal chmnotmpic function of the sinus 
node was retained in a number of patients. this ran be 
approximated by the simpler approaches ai AV iunctional 
a&ion with insertion oE an absptive rate pace~ker. At 
this point in time. this latter appmach. which doer not 
require a thomcotomy. will be -&e appealing for most 
patients. 
ConchtGms. This guarded assessment of the clinical 
results of the corridor opauion is 1101 meant to minimize 
the value of the contributions of this study. Old problems 
remain unsolved when no one questions the idea that 
they are unsolvable and new approaches are not tested. 
The innovative spFroach by Leitch et al. (I) may represent 
the first step to improvine. manaaement of patients with 
atrial fibrill&on. Odly time will tell whethe; it is headed 
in the right direction and how many more steps will be 
needed. - 

